103
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Value of Serum Adiponectin Combined with ABCD2 in Predicting Cerebral Infarction Among Patients with Acute Isolated Vertigo

, &
Pages 1553-1559 | Received 22 Apr 2022, Accepted 21 Jul 2022, Published online: 29 Jul 2022

References

  • Savitz SI, Caplan LR. Vertebrobasilar disease. N Engl J Med. 2005;352(25):2618–2626. doi:10.1056/NEJMra041544
  • Lee CC, Su YC, Ho HC, et al. Risk of stroke in patients hospitalized for isolated vertigo: a four-year follow-up study. Stroke. 2011;42(1):48–52. doi:10.1161/STROKEAHA.110.597070
  • Lee SH, Kim JS. Acute diagnosis and management of stroke presenting dizziness or vertigo. Neurol Clin. 2015;33(3):687–98, xi. doi:10.1016/j.ncl.2015.04.006
  • Kabra R, Robbie H, Connor SEJ. Diagnostic yield and impact of MRI for acute ischaemic stroke in patients presenting with dizziness and vertigo. Clin Radiol. 2015;70(7):736–742. doi:10.1016/j.crad.2015.01.016
  • Lee SH, Yun SJ, Ryu S, et al. Utility of Neutrophil-to-lymphocyte ratio (NLR) as a predictor of acute infarction in new-onset acute vertigo patients without neurologic and computed tomography abnormalities. J Emerg Med. 2018;54(5):607–614. doi:10.1016/j.jemermed.2017.12.058
  • Zuo L, Zhan YQ, Liu FF, et al. Clinical and laboratory factors related to acute isolated vertigo or dizziness and cerebral infarction. Brain Behav. 2018;8(9):e01092. doi:10.1002/brb3.1092
  • Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet. 2007;369(9558):283–292. doi:10.1016/S0140-6736(07)60150-0
  • Navi BB, Kamel H, Shah MP, et al. Application of the ABCD2 score to identify cerebrovascular causes of dizziness in the emergency department. Stroke. 2012;43(6):1484–1489. doi:10.1161/STROKEAHA.111.646414
  • Kartal AG, Yilmaz S, Yaka E, et al. Diagnostic value of S100B protein in the differential diagnosis of acute vertigo in the emergency department. Acad Emerg Med. 2014;21(7):736–741. doi:10.1111/acem.12420
  • Yanai H, Yoshida H. Beneficial effects of adiponectin on glucose and lipid metabolism and atherosclerotic progression: mechanisms and perspectives. Int J Mol Sci. 2019;20(5):1190. doi:10.3390/ijms20051190
  • Wang ZL, Li B, Wang YX, et al. The association between serum adiponectin and 3-month outcome after ischemic stroke. Cardiovasc Diabetol. 2019;18(1). doi:10.1186/s12933-019-0908-z
  • Rizzo MR, Fasano R, Paolisso G. Adiponectin and cognitive decline. Int J Mol Sci. 2020;21(6):2010. doi:10.3390/ijms21062010
  • van Andel M, van Schoor NM, Korten NC, Comijs HC, Heijboer AC, Drent ML. The association between high-molecular-weight adiponectin, ghrelin and leptin and age-related cognitive decline: results from longitudinal aging study Amsterdam. J Gerontol Ser A. 2021;76(1):131–140. doi:10.1093/gerona/glaa126
  • Neuhauser HK, von Brevern M, Radtke A, et al. Epidemiology of vestibular vertigo - A neurotologic survey of the general population. Neurology. 2005;65(6):898–904. doi:10.1212/01.wnl.0000175987.59991.3d
  • Doijiri R, Uno H, Miyashita K, Ihara M, Nagatsuka K. How commonly is stroke found in patients with isolated vertigo or dizziness attack? J Stroke Cerebrovasc Dis. 2016;25(10):2549–2552. doi:10.1016/j.jstrokecerebrovasdis.2016.06.038
  • Marzo SJ, Leonetti JP. The importance of magnetic resonance imaging in the evaluation of vertigo and imbalance. Skull Base Surg. 2000;10(4):171–172. doi:10.1055/s-2000-9334
  • Wu CC, Tsai CH, Lu YC, et al. Contribution of adiponectin and its type 1 receptor to age-related hearing impairment. Neurobiol Aging. 2015;36(6):2085–2093. doi:10.1016/j.neurobiolaging.2015.02.030
  • Matsumoto M, Ishikawa S, Kajii E. Association of adiponectin with cerebrovascular disease: a nested case-control study. Stroke. 2008;39(2):323–328. doi:10.1161/STROKEAHA.107.497552
  • Yang Y, Hu W, Jiang S, et al. The emerging role of adiponectin in cerebrovascular and neurodegenerative diseases. Biochim Biophys Acta. 2015;1852(9):1887–1894. doi:10.1016/j.bbadis.2015.06.019
  • Chen MP, Tsai JCR, Chung FM, et al. Hypoadiponectinemia is associated with ischemic cerebrovascular disease. Arterioscler Thromb Vasc Biol. 2005;25(4):821–826. doi:10.1161/01.ATV.0000157784.25920.a7
  • Bai H, Zhao L, Liu HX, et al. Adiponectin confers neuroprotection against cerebral ischemia-reperfusion injury through activating the cAMP/PKA-CREB-BDNF signaling. Brain Res Bull. 2018;143:145–154. doi:10.1016/j.brainresbull.2018.10.013
  • Liu B, Liu J, Wang JG, et al. Adiponectin protects against cerebral ischemic injury through AdipoR1/AMPK pathways. Front Pharmacol. 2019;10:597.
  • Tu WJ, Qiu HC, Liu YK, Liu Q, Zeng XW, Zhao JZ. Elevated levels of adiponectin associated with major adverse cardiovascular and cerebrovascular events and mortality risk in ischemic stroke. Cardiovasc Diabetol. 2020;19(1). doi:10.1186/s12933-020-01096-3